Tech Company Financing Transactions
CytoTronics Funding Round
CytoTronics secured a $13.5 million Seed funding round on 9/5/2024. Investors included Lyfe Capital, Anzu Partners and Draper Associates.
Transaction Overview
Company Name
Announced On
9/5/2024
Transaction Type
Venture Equity
Amount
$13,500,000
Round
Seed
Investors
Lyfe Capital (Lead Investor)
Anzu Partners (Jenna Abelli)
Proceeds Purpose
The company intends to use the funds to build off its early access program and accelerate market entry of their semiconductor-to-live-cell interface for cell biology applications, Pixel�.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
38 Wareham St
Boston, MA 02118
United States
Boston, MA 02118
United States
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
CytoTronics, a biotechnology company building a next-generation complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Michele Giovenelli
Co-Founder
Duane Sword
Co-Founder
Vince Wu
Browse more venture capital transactions:
Prev: 9/5/2024: Laravel venture capital transaction
Next: 9/5/2024: Acuvity venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs